An update of teriflunomide for treatment of multiple sclerosis

Jiwon Oh,1,2 Paul W O’Connor2 1Department of Neurology, Johns Hopkins University, Baltimore, MD, USA; 2Division of Neurology, St Michael’s Hospital, Toronto, ON, Canada Abstract: There are a number of oral agents emerging as potential disease-modifying agents in multiple sclerosi...

Full description

Bibliographic Details
Main Authors: Oh J, O'Connor PW
Format: Article
Language:English
Published: Dove Medical Press 2013-04-01
Series:Therapeutics and Clinical Risk Management
Online Access:http://www.dovepress.com/an-update-of-teriflunomide-for-treatment-of-multiple-sclerosis-a12869